ArticleCancers2022

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.

Sebastian C B Bremer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.